March 2, 2020 / 12:49 PM / a month ago

BRIEF-Insulet Provides Update On Pivotal Study Of Omnipod Horizon

March 2 (Reuters) - Insulet Corp:

* INSULET PROVIDES UPDATE ON PIVOTAL STUDY OF OMNIPOD HORIZON™

* INSULET - PLANS TO PAUSE PIVOTAL STUDY OF OMNIPOD HORIZON AUTOMATED GLUCOSE CONTROL SYSTEM TO CORRECT SOFTWARE ANOMALY

* INSULET - IDENTIFIED ANOMALY COULD RESULT IN SYSTEM USING AN INCORRECT GLUCOSE VALUE WHICH HAS POTENTIAL TO IMPACT INSULIN DELIVERY

* INSULET - ISSUE IS RARE, BUT BECAUSE OF POTENTIAL TO AFFECT INSULIN DELIVERY, COMPANY WILL PAUSE STUDY UNTIL ANOMALY IS CORRECTED

* INSULET - NO ADVERSE EVENTS HAVE BEEN REPORTED DUE TO ISSUE WITH OMNIPOD INSULIN MANAGEMENT SYSTEM

* INSULET - EXPECTS UPDATED SOFTWARE WILL BE AVAILABLE BY END OF APRIL 2020

* INSULET - STUDY PAUSE WILL MODESTLY IMPACT TIMING OF BRINGING HORIZON TO MARKET, WHICH IS NOW ANTICIPATED TO HAPPEN IN EARLY 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below